Cell-Free Biomimetic Osteochondral Scaffold for the Treatment of Knee Lesions: Clinical and Imaging Results at 10-Year Follow-up.


Journal

The American journal of sports medicine
ISSN: 1552-3365
Titre abrégé: Am J Sports Med
Pays: United States
ID NLM: 7609541

Informations de publication

Date de publication:
08 2021
Historique:
pubmed: 21 7 2021
medline: 10 8 2021
entrez: 20 7 2021
Statut: ppublish

Résumé

Cell-free devices have been introduced to restore osteochondral defects, avoiding the limitations of cell-based procedures. Among these, an osteochondral scaffold made of type I collagen and hydroxyapatite has been investigated with promising results up to medium-term follow-up. However, the clinical and imaging results over time still need to be documented. To evaluate the clinical outcome and tissue maturation at long-term follow-up after the implantation of the osteochondral scaffold. Case series; Level of evidence, 4. A total of 24 patients (7 women, 17 men; age, 36 ± 9.5 years) underwent surgical implantation of the osteochondral scaffold and were prospectively evaluated before surgery, at 2-, 5-, and 10-year follow-up. The mean defect size was 2.9 ± 1.4 cm A statistically significant improvement of all clinical scores was documented from the baseline to the final evaluation. The IKDC subjective score improved from the preoperative level to 2 years (41 ± 13.2 and 77.1 ± 14.6, respectively) ( The regenerative potential of this scaffold is limited, as demonstrated by the signal alterations persisting over time on MRI scans. On the other hand, the clinical improvement was significant and stable over time both in terms of subjective and objective outcomes, including activity level, with overall good results.

Sections du résumé

BACKGROUND
Cell-free devices have been introduced to restore osteochondral defects, avoiding the limitations of cell-based procedures. Among these, an osteochondral scaffold made of type I collagen and hydroxyapatite has been investigated with promising results up to medium-term follow-up. However, the clinical and imaging results over time still need to be documented.
PURPOSE
To evaluate the clinical outcome and tissue maturation at long-term follow-up after the implantation of the osteochondral scaffold.
STUDY DESIGN
Case series; Level of evidence, 4.
METHODS
A total of 24 patients (7 women, 17 men; age, 36 ± 9.5 years) underwent surgical implantation of the osteochondral scaffold and were prospectively evaluated before surgery, at 2-, 5-, and 10-year follow-up. The mean defect size was 2.9 ± 1.4 cm
RESULTS
A statistically significant improvement of all clinical scores was documented from the baseline to the final evaluation. The IKDC subjective score improved from the preoperative level to 2 years (41 ± 13.2 and 77.1 ± 14.6, respectively) (
CONCLUSION
The regenerative potential of this scaffold is limited, as demonstrated by the signal alterations persisting over time on MRI scans. On the other hand, the clinical improvement was significant and stable over time both in terms of subjective and objective outcomes, including activity level, with overall good results.

Identifiants

pubmed: 34283948
doi: 10.1177/03635465211029292
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2645-2650

Auteurs

Alessandro Di Martino (A)

SC II Clinica Ortopedica, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Francesco Perdisa (F)

SC Chirurgia Protesica e dei Reimpianti di Anca e di Ginocchio; IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Giuseppe Filardo (G)

ATRC; IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Maurizio Busacca (M)

SC Radiologia diagnostica ed interventistica, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Elizaveta Kon (E)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.

Maurilio Marcacci (M)

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.

Stefano Zaffagnini (S)

SC II Clinica Ortopedica, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH